Skip to Content

Committed to Safety: As we resume services, we are taking all necessary precautions to keep you safe while we care for you. Limited visitation is now in place. Review all our visitor policies and precautions. Get more information on COVID-19.

Published on September 25, 2020

Virtual Women’s Only Underway

While the 5K has begun, it is not too late to join the event.

 

 The Cone Health Women’s Only 5K Walk & Run Virtual Race is underway. However, it is still not too late to join the effort to help women find breast cancer and support those who have it. Registration is open at womensonly.com until 4 p.m. on October 3 and participants can complete the virtual course through midnight Oct. 3.

The $40 registration fees ($10 for girls 6 and younger) benefit the Mammography Scholarship Fund and the Cone Health Alight Program. The Mammography Scholarship Fund provides screening mammograms to women who are uninsured or can’t pay for the screening. The Alight Program helps with the everyday needs of breast cancer patients in treatment, such as financial assistance, educational materials, peer mentoring and support groups. 

“The money raised in this event really makes a difference in the lives of women throughout our area,” says Debbie Cunningham, DNP, RN, senior vice president, women's, children's and behavioral health services. “I want to remind runners that they still have time to join us. I want to thank our 30 plus sponsors and the runners who have already signed up. You are all heroes to our patients and cancer center staff.”

At registration, participants will find instructions for downloading an app that will put them on a virtual course. Runners can choose their own course, but only those using the official course are eligible for top-finisher prizes. Anyone that finishes the race is entered into raffle drawings for more prizes. Everyone is asked to send photos to #WO5K

The cancer experts at Cone Health Cancer Center treat more cases of breast cancer than any other type. In 2019, 1,003 patients were diagnosed and/or received treatment for newly diagnosed breast cancer.